Merlin Labs

Boston, MA Aerospace & Defense Public

Merlin Labs develops autonomous flight technology for defense and civilian aircraft. The company's core offering, the Merlin Pilot, is an aircraft-agnostic AI-powered software platform that enables takeoff-to-touchdown autonomous flight capabilities, combining high-assurance flight control algorithms with machine learning. With over $100M in prime defense contracts from USSOCOM and other military customers, Merlin is advancing autonomous aviation for both legacy and next-generation aircraft platforms.

Public Company

Merlin Labs is publicly traded

This company is no longer available on our private secondary market. Shares can be traded publicly under its listed ticker.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2017

Employees

180–195

Total Funding

$330M

4 rounds

Latest Valuation

$0.25B

2026

Funding

Total raised $330M across 4 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-25-2026

Latest Round

Type

SPAC merger / public listing (completed)

Date

2026

Amount

~$200M+ raised

Valuation

$0.8B

Lead Investors

Inflection Point Acquisition Corp. IV (Bleichroeder)
DateRoundAmount RaisedValuationLead Investors
2026 SPAC merger / public listing (completed) ~$200M+ raised $0.8B Inflection Point Acquisition Corp. IV (Bleichroeder)
July 13, 2022 Series B $105M Snowpoint Ventures, Baillie Gifford
May 26, 2021 Seed $3.5M First Round Capital

Funding by Round

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Valuation Trajectory

Valuation indexed to 1.0× at the selected entry round. Valuation marks are estimates and may contain errors. Hover each dot to compare.

If you invested at:
1x 2x 2022 2023 2024 2025 2026 Merlin Labs

Entry · Series A

$0.3B

May 2021

Merlin Labs today

$0.8B

Mar 2026 · latest mark

Merlin Labs multiple

3.2x

valuation uplift since first round

Y-axis is logarithmic. Hollow dots = estimated valuations. Does not represent realized investor returns.

Leadership

  • Matt George

    Founder, Chairman and Chief Executive Officer

    LinkedIn
  • Soo Cho

    Chief Operating Officer

  • Ryan Carrithers

    Chief Financial Officer

Merlin Labs Investment FAQ

Merlin Labs FAQ

Merlin Labs completed a business combination with Inflection Point Acquisition Corp. IV on March 16, 2026, and began trading on NASDAQ under ticker symbol MRLN on March 17, 2026. The SPAC transaction raised approximately $200 million in gross proceeds, including a fully committed PIPE anchored by Inflection Point Asset Management, with pre-money valuation of $800 million.

Merlin Labs shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker to place an order.

Merlin Labs had a valuation of approximately $0.25B at the time of its public offering. Current market capitalization fluctuates with the share price.

Merlin Labs raised $330M across 4 disclosed funding rounds prior to its public listing.

Merlin Labs was founded by Matt George in 2017.

Merlin Labs is headquartered in Boston, MA.

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.